Search research articles
Contact Us
Filters
Showing results (211-220 of 282) with videos related to
Page
of 29
Sort By:
European Journal of Clinical Pharmacology
|
May 14, 2003
Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study
Wim J Tamminga, Johan Wemer, Berend Oosterhuis, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 25, 2012
Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictions
Sarah Kleijnen, Elisabeth George, Scott Goulden, et al.
Pharmacogenomics
|
August 18, 2010
Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction
Bas J M Peters, Andrei S Rodin, Olaf H Klungel, et al.
Journal of Medical Internet Research
|
June 23, 2022
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis
Rawa Kamaran Ismail, Jesper van Breeschoten, Silvia van der Flier, et al.
British Journal of Clinical Pharmacology
|
November 27, 2021
Opioid use is associated with increased out-of-hospital cardiac arrest risk among 40 000-cases across two countries
Talip E Eroglu, Carlo A Barcella, Marieke T Blom, et al.
Pharmacoepidemiology and Drug Safety
|
April 3, 2016
Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction
Md Jamal Uddin, Rolf H H Groenwold, Anthonius de Boer, et al.
Thrombosis Research
|
May 10, 2015
Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants
Camilla L Marvig, Talitha I Verhoef, Anthonius de Boer, et al.
Clinical Pharmacology and Therapeutics
|
July 4, 2006
VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation
Tom Schalekamp, Bjorn P Brassé, Janine F M Roijers, et al.
Plos One
|
October 1, 2011
Differential changes in QTc duration during in-hospital haloperidol use
Marieke T Blom, Abdennasser Bardai, Barbara C van Munster, et al.
Clinical Drug Investigation
|
January 16, 2013
Pharmacotherapy of Hospitalised HIV-Infected Patients in a General Hospital during 1990, 1997 and 2001
Monique M R de Maat, Teun M Post, Daniël M Jonker, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 282) with videos related to
Sort By:
Page
of 29
European Journal of Clinical Pharmacology
|
May 14, 2003
Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study
Wim J Tamminga, Johan Wemer, Berend Oosterhuis, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 25, 2012
Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictions
Sarah Kleijnen, Elisabeth George, Scott Goulden, et al.
Pharmacogenomics
|
August 18, 2010
Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction
Bas J M Peters, Andrei S Rodin, Olaf H Klungel, et al.
Journal of Medical Internet Research
|
June 23, 2022
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis
Rawa Kamaran Ismail, Jesper van Breeschoten, Silvia van der Flier, et al.
British Journal of Clinical Pharmacology
|
November 27, 2021
Opioid use is associated with increased out-of-hospital cardiac arrest risk among 40 000-cases across two countries
Talip E Eroglu, Carlo A Barcella, Marieke T Blom, et al.
Pharmacoepidemiology and Drug Safety
|
April 3, 2016
Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction
Md Jamal Uddin, Rolf H H Groenwold, Anthonius de Boer, et al.
Thrombosis Research
|
May 10, 2015
Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants
Camilla L Marvig, Talitha I Verhoef, Anthonius de Boer, et al.
Clinical Pharmacology and Therapeutics
|
July 4, 2006
VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation
Tom Schalekamp, Bjorn P Brassé, Janine F M Roijers, et al.
Plos One
|
October 1, 2011
Differential changes in QTc duration during in-hospital haloperidol use
Marieke T Blom, Abdennasser Bardai, Barbara C van Munster, et al.
Clinical Drug Investigation
|
January 16, 2013
Pharmacotherapy of Hospitalised HIV-Infected Patients in a General Hospital during 1990, 1997 and 2001
Monique M R de Maat, Teun M Post, Daniël M Jonker, et al.
Page
of 29